A Pilot Study Evaluating the Safety, Tolerability, and Efficacy of Doxorubicin and Pembrolizumab in Patients with Metastatic or Unresectable Soft Tissue Sarcoma.

Michael B. Livingston,Megan Jagosky,Myra M. Robinson,William Ahrens,Jennifer H. Benbow,Carol J. Farhangfar,David Foureau,Deirdre Maxwell,Emily Baldrige,Nury Steuerwald,Colin J. Anderson,Joshua Patt,Jeffrey Kneisl,Edward S. Kim

Journal of clinical oncology（2020）

引用 4|浏览49

暂无评分

摘要

11519Background: Doxorubicin has been the traditional standard therapy for treatment of advanced soft tissue sarcoma (STS). The addition of cytotoxic agents leads to increased toxicity with minimal...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要